Cardiovascular Revascularization Medicine
Volume 11, Issue 3 , Pages 140-148 , July 2010

Vascular responses to the multiple overlapped paclitaxel-eluting stents for the treatment of bare-metal in-stent restenotic lesions: angiographic and intravascular ultrasound analysis from the TAXUS-V ISR Trial

  • Tomomi Koizumi

      Affiliations

    • Stanford University, Stanford, CA, USA
    • ,
  • Peter J. Fitzgerald

      Affiliations

    • Stanford University, Stanford, CA, USA
    • Corresponding Author InformationCorresponding author. Center for Cardiovascular Technology, Stanford University 300 Pasteur Drive, Rm H3554, Stanford, CA 94305-5637, USA. Tel.: +1 650 498 6034; fax: +1 650 498 6027.
    • ,
  • Yasuhiro Honda

      Affiliations

    • Stanford University, Stanford, CA, USA
    • ,
  • Stephen G. Ellis

      Affiliations

    • Cleveland Clinic Foundation, Cleveland, OH, USA
    • ,
  • Kenneth Kent

      Affiliations

    • Washington Cardiology Center, Washington, DC, USA
    • ,
  • Steven L. Martin

      Affiliations

    • Nebraska Heart Institute, Lincoln, NE, USA
    • ,
  • Charles L. Brown

      Affiliations

    • Piedmont Hospital, Atlanta, GA, USA
    • ,
  • A.R. Zaki Masud

      Affiliations

    • Buffalo General Hospital, Buffalo, NY, USA
    • ,
  • John B. Patterson

      Affiliations

    • Forsyth Medical Center, Winston-Salem, NC
    • ,
  • Joel Greenberg

      Affiliations

    • Florida Heart Institute, Orlando, FL, USA
    • ,
  • Mark Friedman

      Affiliations

    • Boston Scientific Corporation, Natick, MA, USA
    • ,
  • Takahiro Uchida

      Affiliations

    • Boston Scientific Corporation, Natick, MA, USA
    • ,
  • Gregg W. Stone

      Affiliations

    • Columbia University Medical Center/Cardiovascular Research Foundation, New York, NY

Received 28 June 2009 ,Accepted 8 July 2009.

References 

  1. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, et al A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350(3):221–231
  2. Weissman NJ, Koglin J, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, et al Polymer-based paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation: a serial volumetric intravascular ultrasound analysis from the TAXUS-IV trial. J Am Coll Cardiol. 2005;45(8):1201–1205
  3. Serruys PW, Foley DP, Suttorp MJ, Rensing BJ, Suryapranata H, Materne P, et al A randomized comparison of the value of additional stenting after optimal balloon angioplasty for long coronary lesions: final results of the additional value of NIR stents for treatment of long coronary lesions (ADVANCE) study. J Am Coll Cardiol. 2002;39(3):393–399
  4. Hoffmann R, Herrmann G, Silber S, Braun P, Werner GS, Hennen B, et al. Randomized comparison of success and adverse event rates and cost effectiveness of one long versus two short stents for treatment of long coronary narrowings. Am J Cardiol. 2002;90(5):460–464
  5. Kobayashi Y, De Gregorio J, Kobayashi N, Akiyama T, Reimers B, Finci L, et al. Stented segment length as an independent predictor of restenosis. J Am Coll Cardiol. 1999;34(3):651–659
  6. Stone GW, Ellis SG, Cannon L, Mann JT, Greenberg JD, Spriggs D, et al Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA. 2005;294(10):1215–1223
  7. Tsagalou E, Chieffo A, Iakovou I, Ge L, Sangiorgi GM, Corvaja N, et al. Multiple overlapping drug-eluting stents to treat diffuse disease of the left anterior descending coronary artery. J Am Coll Cardiol. 2005;45(10):1570–1573
  8. Aoki J, Ong AT, Rodriguez Granillo GA, McFadden EP, van Mieghem CA, Valgimigli M, et al “Full metal jacket” (stented length> or=64 mm) using drug-eluting stents for de novo coronary artery lesions. Am Heart J. 2005;150(5):994–999
  9. Degertekin M, Arampatzis CA, Lemos PA, Saia F, Hoye A, Daemen J, et al Very long sirolimus-eluting stent implantation for de novo coronary lesions. Am J Cardiol. 2004;93(7):826–829
  10. Aoki J, Mintz GS, Weissman NJ, Mann JT, Cannon L, Greenberg J, et al. Chronic arterial responses to overlapping paclitaxel-eluting stents. Insights from serial intravascular ultrasound analysis in the TAXUS-V and VI trials. J Am Coll Cardiol Intv. 2008;1:161–167
  11. Stone GW, Ellis SG, O'Shaughnessy CD, Martin SL, Satler L, McGarry T, et al Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial. JAMA. 2006;295(11):1253–1263
  12. Holmes DR, Teirstein P, Satler L, Sketch M, O'Malley J, Popma JJ, et al Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial. JAMA. 2006;295(11):1264–1273
  13. Wilson GJ, Polovick JE, Huibregtse BA, Poff BC. Overlapping paclitaxel-eluting stents: Long-term effects in a porcine coronary artery model. Cardiovasc Res. 2007;76(2):361–372
  14. Kereiakes DJ, Wang H, Popma JJ, Kuntz RE, Donohoe DJ, Schofer J, et al. Periprocedural and late consequences of overlapping Cypher sirolimus-eluting stents: pooled analysis of five clinical trials. J Am Coll Cardiol. 2006;48(1):21–31
  15. Chu WW, Kuchulakanti PK, Torguson R, Wang B, Clavijo LC, Suddath WO, et al. Impact of overlapping drug-eluting stents in patients undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv. 2006;67(4):595–599
  16. Lim VY, Buellesfeld L, Gerckens U, Mueller R, Schmidt T, Grube E. Use of Taxus polymer-coated paclitaxel-eluting stents for treatment of in-stent restenosis in real world patients: results of clinical and angiographic follow-up at six months in a single-center registry. Catheter Cardiovasc Interv. 2006;68(3):343–348
  17. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, et al Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med. 2007;356(10):998–1008
  18. Tanabe K, Serruys PW, Grube E, Smits PC, Selbach G, van der Giessen WJ, et al TAXUS III Trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation. Circulation. 2003;107(4):559–564

PII: S1553-8389(09)00245-0

doi: 10.1016/j.carrev.2009.07.004

Cardiovascular Revascularization Medicine
Volume 11, Issue 3 , Pages 140-148 , July 2010

Article Tools

* Image Usage & Resolution